National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Hyman, Bradley T., Phelps, Creighton H., Beach, Thomas G., Bigio, Eileen H., Cairns, Nigel J., Carrillo, Maria C., Dickson, Dennis W., Duyckaerts, Charles +10 more·2012·Alzheimer's & Dementia
DOI 10.1016/j.jalz.2011.10.007

Cited by (1,029)

Items 701–800 of 1,029

  1. Synapse Stability in the Precuneus Early in the Progression of Alzheimer's Disease
    Stephen W. Scheff, DOUGLAS A. PRICE, Frederick A. Schmitt, Kelly N. Roberts, Miloš D. Ikonomović, Elliott Jay Mufson · 2013 · Journal of Alzheimer s Disease
  2. Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer’s Disease Biomarkers
    Anna Malishkevich, Gad A. Marshall, Aaron P. Schultz, Reisa Anne Sperling, Judith Aharon‐Peretz, Illana Gozes · 2016 · Journal of Alzheimer s Disease
  3. Chronic Traumatic Encephalopathy Presenting as Alzheimer’s Disease in a Retired Soccer Player
    Lea T. Grinberg, Renato Anghinah, Camila Fernandes Nascimento, Edson Amaro, Renata P. Leite, Maria da Graça Morais Martin, Michel Satya Naslavsky, Leonel Tadao Takada, Wilson Jacob Filho, Carlos Augusto Pasqualucci et al. · 2016 · Journal of Alzheimer s Disease
  4. Regulator of Cell Cycle (RGCC) Expression during the Progression of Alzheimer's Disease
    Scott Counts, Elliott Jay Mufson · 2017 · Cell Transplantation
  5. Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease
    Simone Lista, Nicola Toschi, Filippo Baldacci, Henrik Zetterberg, Kaj Blennow, Ingo Kilimann, Stefan Johannes Teipel, Enrica Cavedo, Antonio Melo dos Santos, Stéphane Epelbaum et al. · 2017 · Neurochemistry International
  6. 18F PET with florbetapir for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
    Gabriel Martínez, Robin W.M. Vernooij, Paulina Fuentes Padilla, Javier Zamora, Xavier Bonfill, Leon A Flicker · 2017 · Cochrane Database of Systematic Reviews
  7. Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability
    Rita Cacace, Bavo Heeman, Sara Van Mossevelde, Arne De Roeck, Julie Hoogmartens, Peter De Rijk, Helena Gossye, Kristof De Vos, Wouter De Coster, Mojca Stražišar et al. · 2019 · Acta Neuropathologica
  8. The Full Spectrum of Alzheimer’s Disease Is Rooted in Metabolic Derangements That Drive Type 3 Diabetes
    Suzanne M. de la Monte · 2019 · Advances in experimental medicine and biology
  9. Caring for older people living alone with dementia: Healthcare professionals’ experiences
    Lorna de Witt, Jenny Ploeg · 2014 · Dementia
  10. Canine Cognitive Dysfunction (CCD) scores correlate with amyloid beta 42 levels in dog brain tissue
    Silvan R. Urfer, Martin Darvas, Kálmán Czeibert, Sára Sándor, Daniel Promislow, Kate E. Creevy, Enikö Kubinyi B, Matt R. Kaeberlein · 2021 · GeroScience
  11. Gut microbiota changes in patients with Alzheimer’s disease spectrum based on 16S rRNA sequencing: a systematic review and meta-analysis
    Hui Li, Xiaopan Cui, Yuxiu Lin, Fengqiong Huang, Ayong Tian, Rongwei Zhang · 2024 · Frontiers in Aging Neuroscience
  12. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer’s disease
    Chengyu Zou, Elena Montagna, Yuan Shi, Finn Peters, Lidia Blázquez‐Llorca, Song Shi, Severin Filser, Mario M. Dorostkar, Jochen Wolfgang Herms · 2015 · Acta Neuropathologica
  13. A 2-process model for neuropathology of Alzheimer's disease
    Mungas, Dan, Tractenberg, Rochelle, Schneider, Julie A., Crane, Paul K., Bennett, David A. · 2014 · Neurobiology of Aging
  14. Proteolytic Cleavage of Apolipoprotein E4 as the Keystone for the Heightened Risk Associated with Alzheimer’s Disease
    Troy T. Rohn · 2013 · International Journal of Molecular Sciences
  15. An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease
    Lidia Sarro, Nirubol Tosakulwong, Christopher G. Schwarz, Jonathan Graff‐Radford, Scott A. Przybelski, Timothy G. Lesnick, Samantha M. Zuk, Robert I. Reid, Mekala R. Raman, Bradley F. Boeve et al. · 2016 · Alzheimer s & Dementia
  16. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration
    Joery Goossens, Maria Bjerke, Sara Van Mossevelde, Tobi Van den Bossche, Johan Goeman, Bart B De Vil, Anne Sieben, Jean‐Jacques Martin, Patrick P Cras, Peter Paul De Deyn et al. · 2018 · Alzheimer s Research & Therapy
  17. The spectrum of preclinical Alzheimer's disease pathology and its modulation by ApoE genotype
    Olga Pletniková, Yusuke Kageyama, Gay L. Rudow, Katherine D. LaClair, Marilyn Albert, Barbara J. Crain, Jing Tian, David R. Fowler, Juan Carlos Troncoso · 2018 · Neurobiology of Aging
  18. Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer’s Disease
    Chakrabarti, Mrinmay, McDonald, Alexander J., Will Reed, J., Moss, Melissa A., Das, Bhaskar C., Ray, Swapan K. · 2016 · Journal of Alzheimer's Disease
  19. Accuracy of Biomarker Testing for Neuropathologically Defined Alzheimer Disease in Older Adults With Dementia: A Systematic Review
    Fink, Howard A., Linskens, Eric J., Silverman, Pombie C., McCarten, J. Riley, Hemmy, Laura S., Ouellette, Jeannine M., Greer, Nancy L., Wilt, Timothy J., Butler, Mary · 2020 · Annals of Internal Medicine
  20. Subregional Density of Neurons, Neurofibrillary Tangles and Amyloid Plaques in the Hippocampus of Patients With Alzheimer’s Disease
    Diana Furcila, Marta Domínguez-Álvaro, Javier DeFelipe, Lidia Alonso‐Nanclares · 2019 · Frontiers in Neuroanatomy
  21. Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative
    on behalf of the FACEHBI study group, Marta Marquié, Sergi Valero, Miguel Castilla-Marti, Joan Martínez, Octavio Rodríguez‐Gómez, Ángela Sanabria, Juan Pablo Tartari, Gemma C. Monté, Óscar Sotolongo‐Grau et al. · 2020 · Alzheimer s Research & Therapy
  22. Alzheimer’s disease brain contains tau fractions with differential prion-like activities
    Longfei Li, Ruirui Shi, Jianlan Gu, Yunn Chyn Tung, Yan Zhou, Dingwei Zhou, Ruozhen Wu, Dandan Chu, Nana Jin, Kevin Deng et al. · 2021 · Acta Neuropathologica Communications
  23. Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia
    Marsel M. Mesulam, Christina Coventry, Eileen H. Bigio, Jaiashre Sridhar, Nathan Pruneau Gill, Angela J. Fought, Hui Zhang, Cynthia K. Thompson, Changiz Geula, Tamar D. Gefen et al. · 2021 · Brain
  24. Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease
    Kristi Henjum, Leiv Otto Watne, Kristin Godang, Nathalie Bodd Halaas, Rannveig Sakshaug Eldholm, Kaj Blennow, Henrik Zetterberg, Ingvild Tina Saltvedt, Jens Bollerslev, Anne‐Brita Knapskog · 2022 · Translational Psychiatry
  25. Seizures exacerbate excitatory: inhibitory imbalance in Alzheimer’s disease and 5XFAD mice
    Aaron J Barbour, Sarah Gourmaud, Eunjoo Lancaster, Xiaofan Li, David A. Stewart, Keegan Hoag, David John Irwin, Delia M. Talos, Frances E. Jensen · 2024 · Brain
  26. Brain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer's Disease Neuroimaging Initiative 2 participants
    Erin E. Franklin, Richard J. Perrin, Benjamin D. Vincent, Michael Baxter, John C. Morris, Nigel J. Cairns, Alzheimer’s Disease Neuroimaging Initiative · 2015 · Alzheimer s & Dementia
  27. Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease
    David Alan Bennett, Lei Yu, Philip L. De Jager · 2014 · Biochemical Pharmacology
  28. An Evaluation of MSDC-0160, A Prototype mTOT Modulating Insulin Sensitizer, in Patients with Mild Alzheimer’s Disease
    Raj C. Shah, Dawn C. Matthews, Randolph D. Andrews, Ana Werneck Capuano, Debra A. Fleischman, James T. VanderLugt, Jerry R. Colca · 2014 · Current Alzheimer Research
  29. Neurobiology of cognitive impairment in Parkinson’s disease
    K. A. Jellinger · 2012 · Expert Review of Neurotherapeutics
  30. Precision Medicine
    Brenna Cholerton, Eric Berg Larson, Joseph F. Quinn, Cyrus P. Zabetian, Ignacio Fernandez Mata, Christopher Dirk Keene, Margaret E. Flanagan, Paul K. Crane, Thomas J. Grabowski, Kathleen S. Montine et al. · 2015 · American Journal Of Pathology
  31. Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex
    Emma L. Ashby, James Scott Miners, Patrick G. Kehoe, Seth Love · 2016 · Journal of Alzheimer s Disease
  32. The phosphatase calcineurin regulates pathological TDP-43 phosphorylation
    Nicole F. Liachko, Aleen D. Saxton, Pamela J. McMillan, Timothy J. Strovas, Heather N. Currey, Laura M. Taylor, Jeanna M. Wheeler, Adrian L. Oblak, Bernardino Francesco Ghetti, Thomas Jude Montine et al. · 2016 · Acta Neuropathologica
  33. Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration
    Ahmed Yousef, John L. Robinson, David John Irwin, Matthew D. Byrne, Linda K. Kwong, Edward B. Lee, Yan Xu, Sharon Xiangwen Xie, Lior Rennert, EunRan R. Suh et al. · 2017 · Acta Neuropathologica Communications
  34. Memory complaints, dementia, and neuropathology in older blacks and whites
    Zoe Arvanitakis, Sue E. Leurgans, Debra A. Fleischman, Julie A. Schneider, Kumar Bharat Rajan, Jeremy J. Pruzin, Raj C. Shah, Denis A. Evans, Lisa Laverne Barnes, David Alan Bennett · 2018 · Annals of Neurology
  35. Association between aluminum in drinking water and incident Alzheimer’s disease in the Canadian Study of Health and Aging cohort
    Nicole Van Dyke, Nagarajkumar Yenugadhati, Nicholas Birkett, Joan Lindsay, Michelle C. Turner, Calvin C. Willhite, Daniel R. Krewski · 2020 · NeuroToxicology
  36. Alzheimer’s disease neuropathology in the hippocampus and brainstem of people with obstructive sleep apnea
    Jessica E. Owen, Bryndís Benediktsdóttir, Elizabeth Cook, Ísleifur Ólafsson, Þórarinn Gíslason, Stephen R. Robinson · 2020 · SLEEP
  37. Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials
    Lu, Ming, Pontecorvo, Michael J., Devous, Michael D., Arora, Anupa K., Galante, Nicholas, McGeehan, Anne, Devadanam, Catherine, Salloway, Stephen P., Doraiswamy, P. Murali, Curtis, Craig et al. · 2021 · JAMA Neurology
  38. Advances in Deep Neuropathological Phenotyping of Alzheimer Disease: Past, Present, and Future
    Mustafa Shakir, Brittany N. Dugger · 2022 · Journal of Neuropathology & Experimental Neurology
  39. Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk
    Clifford R. Jack, Terry M. Therneau, Emily S. Lundt, Heather J. Wiste, Michelle M. Mielke, David S. Knopman, Jonathan Graff‐Radford, Val J. Lowe, Prashanthi Vemuri, Christopher G. Schwarz et al. · 2022 · Brain Communications
  40. Hypothesis review: Alzheimer's overture guidelines
    Isidró Ferrer · 2022 · Brain Pathology
  41. Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and Prognostics
    Mrinmay Dhauria, Ritwick Mondal, Shramana Deb, Gourav Shome, Dipanjan Chowdhury, Shramana Sarkar, Julián Benito‐León · 2024 · International Journal of Molecular Sciences
  42. Cerebral hyperactivation across the Alzheimer’s disease pathological cascade
    Nick Corriveau‐Lecavalier, Jenna N. Adams, Larissa Fischer, Eóin N. Molloy, Anne Maaß · 2024 · Brain Communications
  43. Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology
    Sarah E. Monsell, Charles Mock, Catherine M. Roe, Nupur Ghoshal, John C. Morris, Nigel J. Cairns, Walter A. Kukull · 2013 · Neurology
  44. Clinical Neurophysiological and Automated EEG-Based Diagnosis of the Alzheimer's Disease
    Shreya Bhat, U. Rajendra Acharya, Nahid Dadmehr, Hojjat Adeli · 2015 · European Neurology
  45. Ketogenic diets and Alzheimer’s disease
    Lange, Klaus W., Lange, Katharina M., Makulska-Gertruda, Ewelina, Nakamura, Yukiko, Reissmann, Andreas, Kanaya, Shigehiko, Hauser, Joachim · 2017 · Food Science and Human Wellness
  46. Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease
    Stefan Johannes Teipel, H.-Christian Fritz, Michel J. Grothe, Alzheimer’s Disease Neuroimaging Initiative · 2020 · Neurology
  47. P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
    Juan Lantero‐Rodriguez, Anniina Snellman, Andréa Lessa Benedet, Marta Milà‐Alomà, Elena Camporesi, Laia Montoliu‐Gaya, Nicholas James Ashton, Agathe Vrillon, Thomas K. Karikari, Juan Domingo Gispert et al. · 2021 · EMBO Molecular Medicine
  48. Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer’s disease
    Kim, Chae, Haldiman, Tracy, Kang, Sang-Gyun, Hromadkova, Lenka, Han, Zhuang Zhuang, Chen, Wei, Lissemore, Frances, Lerner, Alan, de Silva, Rohan, Cohen, Mark L. et al. · 2022 · Science Translational Medicine
  49. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer’s Disease Pathology
    Sephira G. Ryman, Maya V. Yutsis, Lü Tian, Victor W. Henderson, Thomas Jude Montine, David P. Salmon, Douglas R Galasko, Kathleen L. Poston · 2021 · Journal of Alzheimer s Disease
  50. A deep ensemble hippocampal CNN model for brain age estimation applied to Alzheimer’s diagnosis
    Katia Maria Poloni, Ricardo José Ferrari · 2022 · Expert Systems with Applications
  51. Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer’s disease neuropathologic changes and cognitive decline
    Ko-Ping Chang, Jonathan P. Ling, Javier Redding-Ochoa, Yang An, Ling Li, Stephanie A Dean, Thomas G. Blanchard, Tatiana Pylyukh, Alexander Barrett, K. E. Irwin et al. · 2023 · Acta Neuropathologica
  52. The Biomarker and Therapeutic Potential of Mirna in Alzheimer’s Disease
    Lynn M. Bekris, James B. Leverenz · 2015 · Neurodegenerative Disease Management
  53. Role of Liver X Receptor in AD Pathophysiology
    Adrián Gabriel Sandoval-Hernández, Luna Buitrago, Herman Moreno, Gloria Patricia Cardona‐Gómez, Gonzálo Arboleda · 2015 · PLoS ONE
  54. An Algorithm for Preclinical Diagnosis of Alzheimer's Disease
    Tapan K. Khan · 2018 · Frontiers in Neuroscience
  55. Prediction models for dementia and neuropathology in the oldest old: the Vantaa 85+ cohort study
    Anette Hall, Timo Pekkala, Tuomo M. Polvikoski, Mark van Gils, Miia Kivipelto, Jyrki M. P. Lötjönen, Jussi Mattila, Mia Kero, Liisa Myllykangas, Mira Mäkelä et al. · 2019 · Alzheimer s Research & Therapy
  56. Selective memory and behavioral alterations after ambient ultrafine particulate matter exposure in aged 3xTgAD Alzheimer’s disease mice
    Katrina Jew, Denise Herr, Candace Wong, Andrea J Kennell, Keith Morris‐Schaffer, Günter Oberdörster, M. Kerry O’Banion, Deborah A. Cory‐Slechta, Alison C. P. Elder · 2019 · Particle and Fibre Toxicology
  57. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer’s disease
    Miloš D. Ikonomović, Christopher J. Buckley, Eric E. Abrahamson, Julia Kofler, Chester A. Mathis, William Edward Klunk, Gill Farrar · 2020 · Acta Neuropathologica
  58. Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer’s disease
    Daniel T. Ohm, Angela J. Fought, Adam Martersteck, Christina Coventry, Jaiashre Sridhar, Tamar D. Gefen, Sandra Weıntraub, Eileen H. Bigio, Marsel M. Mesulam, Emily Joy Rogalski et al. · 2020 · Brain Pathology
  59. ApoE4 attenuates autophagy via FoxO3a repression in the brain
    Sohn, Hee-Young, Kim, Seong-Ik, Park, Jee-Yun, Park, Sung-Hye, Koh, Young Ho, Kim, Joon, Jo, Chulman · 2021 · Scientific Reports
  60. Multi-resolution statistical analysis of brain connectivity graphs in preclinical Alzheimer's disease
    Won Hwa Kim, Nagesh Adluru, Moo Kwon Chung, Ozioma C. Okonkwo, Sterling C. Johnson, Barbara B. Bendlin, Vikas Singh · 2015 · NeuroImage
  61. Identification of multiple system atrophy mimicking Parkinson’s disease or progressive supranuclear palsy
    Yasuo Miki, Eiki Tsushima, Sandrine C. Foti, Kate M Strand, Yasmine T. Asi, Adam Kenji Yamamoto, Conceição Bettencourt, Marcos Castello Barbosa de Oliveira, Eduardo De Pablo‐Fernández, Zane Jaunmuktane et al. · 2021 · Brain
  62. Neuropathologic correlates of cognition in a population-based sample
    B. Cholerton, E. Larson, L. Baker, S. Craft, P. Crane, S. Millard, J. Sonnen, T. Montine · 2013 · Journal of Alzheimer's Disease
  63. Chitinase expression in Alzheimer's disease and non-demented brains regions
    Sanfilippo, C., Malaguarnera, L., Di Rosa, M. · 2016 · Journal of the Neurological Sciences
  64. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
    Gabriel Martínez, Robin W.M. Vernooij, Paulina Fuentes Padilla, Javier Zamora, Leon A Flicker, Xavier Bonfill · 2017 · Cochrane Database of Systematic Reviews
  65. Increased Hyaluronan and TSG-6 in Association with Neuropathologic Changes of Alzheimer’s Disease
    May J. Reed, Mamatha Damodarasamy, Jasmine L. Pathan, Christina K. Chan, Charles F. Spiekerman, Thomas N. Wight, William A. Banks, Anthony J. Day, Robert B. Vernon, Christopher Dirk Keene · 2018 · Journal of Alzheimer s Disease
  66. Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer’s Disease
    Heather M. Buchanan, Murray Mackay, K PALMER, Karolína Tothová, Miroslava Katsur, Bettina Platt, David J. Koss · 2020 · Molecular Neurobiology
  67. Aggregated Tau-PHF6 (VQIVYK) Potentiates NLRP3 Inflammasome Expression and Autophagy in Human Microglial Cells
    Chinmaya Panda, Clara Voelz, Pardes Habib, Christian Mevissen, Thomas Pufe, Cordian Beyer, Sharad Kumar Gupta, Alexander Slowik · 2021 · Cells
  68. Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma
    Baker-Nigh, Alaina T., Mawuenyega, Kwasi G., Bollinger, James G., Ovod, Vitaliy, Kasten, Tom, Franklin, Erin E., Liao, Fan, Jiang, Hong, Holtzman, David, Cairns, Nigel J. et al. · 2016 · Journal of Biological Chemistry
  69. Amyloid Imaging in Atypical Presentations of Alzheimer’s Disease
    David A. Wolk · 2013 · Current Neurology and Neuroscience Reports
  70. Visit-to-Visit Blood Pressure Variability, Neuropathology, and Cognitive Decline
    Yuan Ma, Deborah Blacker, Anand Viswanathan, Susanne J. van Veluw, Daniël Bos, Meike Willemijn Vernooij, Bradley T. Hyman, Christophe Tzourio, Sudeshna Das, Albert Hofman D · 2021 · Neurology
  71. Age-related and amyloid-beta-independent tau deposition and its downstream effects
    Anika Wuestefeld, Alexa Pichet Binette, David Berron, Nicola Spotorno, Danielle van Westen, Erik Stomrud, Niklas Mattsson, Olof T. Strandberg, Ruben A Smith, Sebastian Palmqvist et al. · 2023 · Brain
  72. Neuropathology of Depression in Alzheimer's Disease: Current Knowledge and the Potential for New Treatments
    Ahmad Adam Khundakar, Alan J. Thomas · 2015 · Journal of Alzheimer s Disease
  73. MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies
    Martí Colom‐Cadena, Ellen Gelpí, Marı́a José Martı́, Sara Charif, Oriol Dols‐Icardo, Rafael Blesa, Jordi Clarimón, Alberto Lleó · 2012 · Neurobiology of Aging
  74. Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition
    Dietmar Rudolf Thal, Thomas G. Beach, Michelle Zanette, Johan Lilja, Kerstin Heurling, Aruna Chakrabarty, Azzam Ismail, Gill Farrar, Christopher J. Buckley, Adrian P L Smith · 2018 · Acta Neuropathologica
  75. Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer’s disease
    Lutz Frölich, Glen R. Wunderlich, Claus Thamer, Michael Roehrle, Miguel García, Bruno Dubois · 2019 · Alzheimer s Research & Therapy
  76. Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases
    Gloria Biechele, Nicolai Franzmeier, Tanja Blume, Michael Ewers, José Medina-Luque, Florian Eckenweber, Christian Sacher, Leonie Beyer, François Ruch, Simon Lindner et al. · 2020 · Journal of Neuroinflammation
  77. Blood-Based Biomarkers of Neuroinflammation in Alzheimer’s Disease: A Central Role for Periphery?
    Federica Angiulli, Elisa Conti, C Zoia, Fulvio Da Re, Ildebrando Marco Appollonio, Carlo Ferrarese, Lucio Tremolizzo · 2021 · Diagnostics
  78. The Mechanistic Pathways of Periodontal Pathogens Entering the Brain: The Potential Role of Treponema denticola in Tracing Alzheimer’s Disease Pathology
    Flavio Pisani, Valerio Pisani, Francesca Arcangeli, Alice Harding, Simarjit Kaur Singhrao · 2022 · International Journal of Environmental Research and Public Health
  79. Differential microRNA expression analyses across two brain regions in Alzheimer’s disease
    Valerija Dobričić, Marcel Schilling, Jessica Schulz, Ling‐Shuang Zhu, Chao-Wen Zhou, Janina Fuß, Sören Franzenburg, Ling‐Qiang Zhu, Laura Parkkinen, Christina M. Lill et al. · 2022 · Translational Psychiatry
  80. Asymmetry of neurodegenerative disease-related pathologies: a cautionary note
    Harald Stefanits, Herbert Budka, Gábor Géza Kovács · 2012 · Acta Neuropathologica
  81. Oxidative Stress and Its Clinical Applications in Dementia
    Peizhong Mao · 2012 · Journal of Neurodegenerative Diseases
  82. Matrix metalloproteinase 9–mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy
    Lingzhi Zhao, Michal Arbel‐Ornath, Xueying Wang, Rebecca A. Betensky, Steven Mark Greenberg, Matthew P. Frosch, Brian J. Bacskai · 2015 · Neurobiology of Aging
  83. Primary age-related tauopathy and the amyloid cascade hypothesis: the exception that proves the rule?
    John F. Crary · 2016 · Journal of Neurology and Neuromedicine
  84. Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes
    Mechelle M. Lewis, Guangwei Du, Jennifer Baccon, Amanda M. Snyder, Ben Murie, Felicia Cooper, Christy Stetter, Lan Kong, Christopher T. Sica, Richard B. Mailman et al. · 2018 · Movement Disorders
  85. Coexistence of Multiple Sclerosis and Alzheimer's disease: A review
    Pauline Luczynski, Cornelia Laule, Ging‐Yuek Robin Hsiung, G. R. Wayne Moore, Helen L. Tremlett · 2018 · Multiple Sclerosis and Related Disorders
  86. Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer’s disease neuropathology
    David X. Thomas, Sumali Bajaj, Kevin McRae‐McKee, Christoforos Hadjichrysanthou, Roy Malcolm Anderson, John Collinge · 2020 · Scientific Reports
  87. Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease
    Valentina Berti, Cristina Polito, Gemma Lombardi, Camilla Ferrari, Sandro Sorbi, Alberto Pupi · 2016 · Neurological Sciences
  88. Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model
    Christian Sacher, Tanja Blume, Leonie Beyer, Finn Peters, Florian Eckenweber, Carmelo Sgobio, Maximilian Deußing, Nathalie L. Albert, Marcus Unterrainer, Simon Lindner et al. · 2019 · Journal of Nuclear Medicine
  89. A soluble truncated tau species related to cognitive dysfunction is elevated in the brain of cognitively impaired human individuals
    Peng Liu, Benjamin R. Smith, Michelle L. Montonye, Lisa J. Kemper, Kailee Leinonen-Wright, Kathryn M. Nelson, LeeAnn Higgins, Candace R. Guerrero, Todd W. Markowski, Xiaohui Zhao et al. · 2020 · Scientific Reports
  90. Limbic‐predominant age‐related TDP‐43 encephalopathy neuropathologic change and microvascular pathologies in community‐dwelling older persons
    Sonal Agrawal, Lei Yu, Alifiya Kapasi, Bryan David James, Konstantinos Arfanakis, Lisa Laverne Barnes, David Alan Bennett, Sukriti Nag, Julie A. Schneider · 2021 · Brain Pathology
  91. Diagnosis of Alzheimer’s Disease and In Situ Biological Imaging via an Activatable Near-Infrared Fluorescence Probe
    Yuexia Yang, Liang Zhang, Jiemin Wang, Yuping Cao, Shuyan Li, Wenwu Qin, Yun Liu · 2022 · Analytical Chemistry
  92. A Survey of Deep Learning for Alzheimer’s Disease
    Qinghua Zhou, Jiaji Wang, Xiang Yu, Shuihua Wang‎, Yudong Zhang · 2023 · Machine Learning and Knowledge Extraction
  93. An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies
    Grant Coan, Cassie S. Mitchell · 2015 · Neurodegenerative Diseases
  94. Evolutional Aspects of Alzheimer's Disease Pathogenesis
    Heiko Braak, Kelly Del Tredici · 2012 · Journal of Alzheimer s Disease
  95. Multiple Mechanisms of Iron-Induced Amyloid Beta-Peptide Accumulation in SHSY5Y Cells: Protective Action of Negletein
    Priyanjalee Banerjee, Arghyadip Sahoo, Shruti Anand, Anirban Ganguly, Giuliana Righi, Paolo Bovicelli, Luciano Saso, Sasanka Chakrabarti · 2014 · NeuroMolecular Medicine
  96. The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer’s Disease
    Haobin Cai, Yunxia Luo, Xin Yan, Peng Ding, Yujie Huang, Shuhuan Fang, Rong Zhang, Yunbo Chen, Zhouke Guo, Jiansong Fang et al. · 2018 · Scientific Reports
  97. Depression in Alzheimer’s Disease: An Alternative Role for Selective Serotonin Reuptake Inhibitors?
    Richard J. Elsworthy, Sarah Aldred · 2019 · Journal of Alzheimer s Disease
  98. Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy
    Nicole M. Maphis, Julianne Peabody, Erin Crossey, Shanya Jiang, Fadi Ali Jamaleddin Ahmad, María Javiera Álvarez, Soiba Khalid Mansoor, Amanda Yaney, Yirong Yang, Laurel O. Sillerud et al. · 2019 · npj Vaccines
  99. Small vessel disease pathological changes in neurodegenerative and vascular dementias concomitant with autonomic dysfunction
    Yoshiki Hase, Tuomo M. Polvikoski, Michael Firbank, Lucinda Craggs, Emily Hawthorne, Charlotte Platten, William Stevenson, Vincent Deramecourt, Clive G. Ballard, Rose Anne Kenny et al. · 2019 · Brain Pathology
  100. Renin-Angiotensin System and Alzheimer’s Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives
    Victor Teatini Ribeiro, Leonardo Cruz de Souza, Ana Cristina Simões e Silva · 2019 · Protein and Peptide Letters